Moderna COVID-19 vaccine pediatric clinical trial to focus on ages 6 months to 5 years

The KidCOVE phase three clinical trial at the University of Wisconsin School of Medicine and Public Health, which is evaluating the safety and effectiveness of the Moderna COVID-19 vaccine in children, has shifted focus to kids 6 months to 5-years-old.

In August, enrollment for kids ages 5 to 11 years old closed just days after the nationwide trial opened at the Madison site thanks to a high volume of applicants. Data from that cohort are currently being analyzed by Moderna.

In Madison, dozens of kids ages 6 months to 5 years are participating in the clinical trial at American Family Children’s Hospital. Due to incredible community response in August, study coordinators and researchers have the candidates they need and are not taking more participants. Those who applied previously will be contacted by the researchers if their child is chosen to participate. Read more …